Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Pelekanou

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Transplantation Proceedings|December 1, 1991
FK 506 and rapamycin do not affect platelet aggregation or mitochondrial functionV Pelekanou, A E Trezise, A L Moore, et al.
Chirality|August 9, 2013
Identification of polyproline II regions derived from the proline-rich nuclear receptor coactivators PNRC and PNRC2: new insights for ERα coactivator interactionsC Byrne, E Miclet, I Broutin, et al.
Scientific Reports|June 29, 2022
Quantitative systems pharmacology modeling sheds light into the dose response relationship of a trispecific T cell engager in multiple myelomaR E Abrams, K Pierre, N El-Murr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2018
Immunological differences between primary and metastatic breast cancerB Szekely, V Bossuyt, X Li, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Transplantation Proceedings|December 1, 1991
FK 506 and rapamycin do not affect platelet aggregation or mitochondrial functionV Pelekanou, A E Trezise, A L Moore, et al.
Chirality|August 9, 2013
Identification of polyproline II regions derived from the proline-rich nuclear receptor coactivators PNRC and PNRC2: new insights for ERα coactivator interactionsC Byrne, E Miclet, I Broutin, et al.
Scientific Reports|June 29, 2022
Quantitative systems pharmacology modeling sheds light into the dose response relationship of a trispecific T cell engager in multiple myelomaR E Abrams, K Pierre, N El-Murr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2018
Immunological differences between primary and metastatic breast cancerB Szekely, V Bossuyt, X Li, et al.
Pageof 1